(Cu(4- methylcoumarin- 6,7- dioxactetate)(phenanthroline)2)

Subscribe to Selected New Research on (Cu(4-methylcoumarin-6,7-dioxactetate)(phenanthroline)2)

14 relevant articles (1 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure in first source

Also Known As:

copper(II) complex

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organometallic Compounds: 5

(Cu(4-methylcoumarin-6,7-dioxactetate)(phenanthroline)2): 14

Experts

1.	Kavanagh, Kevin: 1 article (08/2007)
2.	Noble, Andy: 1 article (08/2007)
3.	Egan, Denise A: 1 article (08/2007)
4.	Thati, Bhumika: 1 article (08/2007)
5.	Walsh, Maureen: 1 article (08/2007)
6.	Creaven, Bernadette S: 1 article (08/2007)
7.	Dall'asta, Valeria: 1 article (04/2007)
8.	Tegoni, Matteo: 1 article (04/2007)
9.	Bussolati, Ovidio: 1 article (04/2007)
10.	Giannetto, Marco: 1 article (04/2007)

Related Diseases

1.	Ulcer 11/01/1997 - "The copper(II) complex of L-tryptophan and L-phenylalanine is reported as the most effective in reducing ulcer numbers as well as ulcer severity of the many amino acid complexes studied" Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 08/13/2007 - "Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells." 04/01/2007 - "Synthesis and mass spectroscopy kinetics of a novel ternary copper(II) complex with cytotoxic activity against cancer cells." 04/19/2007 - "Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells." Get all the results and reference details, order at left...
3.	Anoxia (Hypoxia) 01/01/2008 - "In particular, the copper(II) complex with 3-amino-6-chloro-7-fluoroquinoxaline-2-carbonitrile N1,N4-dioxide showed cytotoxic selectivity in hypoxia being the most lipophilic compound of the series" 06/01/2008 - "This paper reviews the research in progress in Oxford on the chemical, spectroscopic and redox properties of bis(thiosemicarbazonato) complexes of zinc and copper in the context of the hypoxia selectivity of the copper(II) complex" Get all the results and reference details, order at left...
4.	Diabetes Complications 07/01/2007 - "A copper(II) complex with the pyridoxal-aminoguanidine (PL-AG) Schiff base adduct, as an organic compound of the very potent biological activity and promising pharmacological importance in the treatment of diabetic complications, has been prepared and characterized" Get all the results and reference details, order at left...
5.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/14/2008 - "Human acute myeloid leukemia cell line HL-60, MTT assay, and Trypan blue assay were used to test the antileukemic, the cell viability, and the structural integrity of the cell membrane and cell proliferation properties of (chloro)(Phen)( N-propyl-norfloxacinato)copper(II) (complex 1), respectively" Get all the results and reference details, order at left...
12 Diseases and 14 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Tryptophan (L-Tryptophan)
2.	Phenylalanine (L-Phenylalanine)
3.	Zinc
4.	Schiff Bases (Schiff Base)
5.	Copper
6.	Trypan Blue
7.	Pyridoxal
8.	DNA (Deoxyribonucleic Acid)
9.	Ascorbic Acid (Vitamin C)
10.	1,10-phenanthroline
14 Drugs and Important Bio-Agents and 10 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>